🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →
Browsing Tag

Australia

722 posts
Read More

Avecho Biotechnology (ASX: AVE) secures Japanese patent for CBD capsule as global licensing strategy expands

Avecho Biotechnology’s Japanese patent adds another major jurisdiction to the intellectual property estate surrounding its TPM-enhanced cannabidiol capsule. The grant strengthens the company’s negotiating position, but clinical completion, regulatory approval and regional licensing remain the decisive commercial tests.
Read More

Worley (ASX: WOR) secures INPEX agreement ahead of full-year results

Worley Limited has strengthened its relationship with INPEX Corporation through a new framework services agreement, adding another established global energy customer to its growing portfolio of long-term arrangements. The agreement creates a pathway for future assignments, although the commercial significance will depend on the value, frequency and margins of work subsequently awarded under the framework.
Read More

Michael Hill International (ASX: MHJ) expects FY26 EBIT to jump up to 57% as same-store sales rise

Michael Hill International has delivered sales growth across Australia, Canada and New Zealand while lifting expected FY26 comparable EBIT by at least 44%. The stronger profit outlook suggests that portfolio simplification and tighter retail execution are gaining traction, although the full-year margin, dividend decision and second-half earnings profile remain important tests.